Yung-chieh Chan

MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.

M. Hsiao, Chia-Yi Su, Y. Chang, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A selective drug delivery system based on phospholipid-type nanobubbles for lung cancer therapy.

M. Hsiao, Ru‐Shi Liu, Yung-chieh Chan, 2020, Nanomedicine.

Development of upconversion nanoparticle-conjugated indium phosphide quantum dot for matrix metalloproteinase-2 cancer transformation sensing.

M. Hsiao, Ru‐Shi Liu, R. Chung, 2019, Nanomedicine.

Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.

M. Huang, M. Hsiao, Chih-Jen Yang, 2017, Cancer letters.

Nanobubble-embedded inorganic 808 nm excited upconversion nanocomposites for tumor multiple imaging and treatment

Chu-Song Chen, Yung-chieh Chan, M. Chan, 2018, Chemical science.